94169-62-7

Usage

Uses

Used in Cosmetic and Personal Care Industry:
METHYL 3,5-DIISOPROPYLOXYBENZOATE is used as a fragrance ingredient for its ability to contribute a pleasant scent and improve the overall aroma of cosmetic and personal care products.
Used in Perfumery:
In the perfume industry, METHYL 3,5-DIISOPROPYLOXYBENZOATE is utilized as a fragrance component, where it helps in enriching the scent profiles of perfumes and colognes.
Used in Pharmaceutical Manufacturing:
METHYL 3,5-DIISOPROPYLOXYBENZOATE is also employed in the production of pharmaceuticals, potentially due to its aromatic properties and possible functional groups that can be utilized in the synthesis of medicinal agents.
Used as a Flavoring Agent in Food Industry:
METHYL 3,5-DIISOPROPYLOXYBENZOATE is used as a flavoring agent in food products, adding a distinct taste and enhancing the overall flavor profile of certain food items.
Safety Precautions:
It is crucial to handle METHYL 3,5-DIISOPROPYLOXYBENZOATE with care, adhering to safety measures to prevent ingestion or contact with skin and eyes, as it can be harmful if not properly managed.

Upstream product

• 2150-44-9 1-carbomethoxy-3,5-dihydroxybenzene 
• 75-26-3 isopropyl bromide 
• 75-30-9 2-iodo-propane 
• 752242-26-5 methyl 3-hydroxy-5-isopropoxybenzoate 

Downstream Products

• 94169-63-8 (3,5-diisopropoxyphenyl)methanol 
• 94169-64-9 3,5-diisopropyloxyphenylcarboxaldehyde 
• 94169-65-0 2-iodo-3,5-di-isopropoxybenzaldehyde 
• 94169-68-3 methyl 2'-iodo-3',5'-di-isopropoxy-4,5,6-trimethoxystylbene-3-carboxylate 
• 94169-69-4 methyl 2'-iodo-3',5'-di-isopropoxy-4,5,6-trimethoxystylbene-3-carboxylate 
• 150242-82-3 3,5-di-(isopropyloxy)benzoic acid 
• 942999-56-6 N-(tert-butyloxycarbonyl)-3,5-di-(isopropoxy)aniline 
• 942999-08-8 3,5-di-(isopropyloxy)aniline hydrochloride 
• 1006584-05-9 C₂₈H₄₀N₂O₆ 
• 1032435-05-4 N-[(3,5-diisopropoxy)phenyl] 4-[(2-amino)ethoxy]-3,5-dimethylbenzamide hydrochloride 
• 1093120-87-6 C₂₂H₂₃ClN₂O₄S 
• 1093120-99-0 C₂₃H₂₃N₃O₄S 
• 1093121-29-9 C₂₄H₂₆N₂O₆S 
• 1093120-82-1 C₂₃H₂₄N₂O₆S 

Relevant academic research and scientific papers

Molecular Dynamics Simulations and Kinetic Measurements to Estimate and Predict Protein-Ligand Residence Times

Ligand-target residence time is emerging as a key drug discovery parameter because it can reliably predict drug efficacy in vivo. Experimental approaches to binding and unbinding kinetics are nowadays available, but we still lack reliable computational to

Modified approach for preparing (E)-Stilbenes related to resveratrol, and evaluation of their potential immunobiological effects

Resveratrol and closely related stilbenoids belong to the most intensively studied biologically active compounds. This interest evoked several attempts to prepare such compounds in a convenient synthetic way. Our approach allowed obtaining largely methoxystilbenes, formed as E-isomers only (using Wittig-Horner synthesis as the key step), which were further demethylated by boron tribromide. The hydroxymethoxystilbenes (e.g. pterostilbene) were prepared using isopropyl protection, later selectively deprotected by boron trichloride. The method is suitable for preparing such compounds in a large amount. Effects of the obtained stilbene derivatives on immunobiological responses triggered by lipopolysacharide and interferon-a were tested under in vitro conditions. Namely production of nitric oxide (NO) was investigated, and relation between the molecular structure and immunobiological activity was assessed.

1, 3 - DIHYDROXY SUBSTITUTED PHENYLAMIDE GLUCOKINASE ACTIVATORS

Compounds are provided which are glucokinase activators and thus are useful in treating diabetes and related diseases and have the structure wherein in the ring represents one or two double bonds; R1 is alkyl, aryl, arylalkyl, heteroaryl, or he

Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator

Fragment-based lead discovery has been applied to urokinase-type plasminogen activator (uPA). The (R)-enantiomer of the orally active drug mexiletine 5 (a fragment hit from X-ray crystallographic screening) was the chemical starting point. Structure-aided

ASPARTYL PROTEASE INHIBITORS

The present invention provides compounds having formula (I): wherein R’, R0, R1, X1, R2, R3, R3’, X2, X3, and R4 are as defined herein, and pharmaceuticals compositions thereof. The present invention also provides methods of inhibiting proteases, more specially aspartyl proteases. In certain embodiments, compounds inhibit BACE (β-site APP-cleaving enzyme), and thus are useful in the treatment or prevention of a disease characterized by β-amyloid deposits in the brain (including, but not limited to, Alzheimer’s Disease). The present invention also provides methods for preparing compounds of the invention.

Phenanthrene Synthesis: Coeloginin a Novel 9,10-Dihydrophenanthrene from the Orchid Coelogyne cristata

The synthesis of 2,6-dihydroxy-7,8-dimethoxy-9,10-dihydro-5H-phenanthropyran-5-one (coeloginin) (1), a natural product isolated from the orchid Coelogyne cristata, is described.The key step involved the treatment of methyl 9,10-dihydro-5,7-di-iso